MY144089A - A medicament related to mirtazapine for the treatment of hot flush - Google Patents

A medicament related to mirtazapine for the treatment of hot flush

Info

Publication number
MY144089A
MY144089A MYPI20055321A MYPI20055321A MY144089A MY 144089 A MY144089 A MY 144089A MY PI20055321 A MYPI20055321 A MY PI20055321A MY PI20055321 A MYPI20055321 A MY PI20055321A MY 144089 A MY144089 A MY 144089A
Authority
MY
Malaysia
Prior art keywords
mirtazapine
treatment
hot flush
medicament
medicament related
Prior art date
Application number
MYPI20055321A
Other languages
English (en)
Inventor
Bernardus Wijnand Mathys Marie Peeters
Anton Egbert Peter Adang
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY144089(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of MY144089A publication Critical patent/MY144089A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
MYPI20055321A 2004-11-15 2005-11-14 A medicament related to mirtazapine for the treatment of hot flush MY144089A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04105778 2004-11-15

Publications (1)

Publication Number Publication Date
MY144089A true MY144089A (en) 2011-08-15

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20055321A MY144089A (en) 2004-11-15 2005-11-14 A medicament related to mirtazapine for the treatment of hot flush

Country Status (30)

Country Link
US (4) US20070265245A1 (enExample)
EP (1) EP1814555B1 (enExample)
JP (1) JP2008519810A (enExample)
KR (1) KR20070085470A (enExample)
CN (2) CN101056641A (enExample)
AR (1) AR053780A1 (enExample)
AT (1) ATE439843T1 (enExample)
AU (1) AU2005303778B2 (enExample)
BR (1) BRPI0517818A2 (enExample)
CA (1) CA2587283C (enExample)
CY (1) CY1110538T1 (enExample)
DE (1) DE602005016141D1 (enExample)
DK (1) DK1814555T3 (enExample)
ES (1) ES2329815T3 (enExample)
HR (1) HRP20090513T1 (enExample)
IL (1) IL182767A (enExample)
MX (1) MX2007005827A (enExample)
MY (1) MY144089A (enExample)
NO (1) NO20072285L (enExample)
NZ (1) NZ554858A (enExample)
PE (1) PE20061051A1 (enExample)
PL (1) PL1814555T3 (enExample)
PT (1) PT1814555E (enExample)
RS (1) RS51138B (enExample)
RU (1) RU2396957C2 (enExample)
SI (1) SI1814555T1 (enExample)
TW (1) TW200631584A (enExample)
UA (1) UA88655C2 (enExample)
WO (1) WO2006051111A1 (enExample)
ZA (1) ZA200703884B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007002174A2 (en) * 2005-06-27 2007-01-04 N.V. Organon. A method of treatment of hormone depletion induced vasomotor symptoms
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
EP1993556A1 (en) * 2006-03-06 2008-11-26 N.V. Organon An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
AU2007324467A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
JP6876003B2 (ja) 2015-02-27 2021-05-26 デクラ リミテッド イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置
KR102608479B1 (ko) * 2017-05-25 2023-12-01 글리테크 엘엘씨. Nmdar 길항제-반응성 신경정신 질환을 위한 병용 요법
WO2021167579A1 (ru) 2020-02-19 2021-08-26 Иван УЛИНИЧ Универсальное устройство для тепловой обработки пищевых продуктов

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
ES2212550T3 (es) * 1998-04-02 2004-07-16 Akzo Nobel N.V. Solucion oral liquida que comprende el antidepresor mirtazapina.
RU2195951C1 (ru) * 2001-08-20 2003-01-10 Общество с ограниченной ответственностью "Лаборатория "Ирис" Средство для лечения климактерических расстройств

Also Published As

Publication number Publication date
AR053780A1 (es) 2007-05-23
CN102772414A (zh) 2012-11-14
MX2007005827A (es) 2007-07-20
ES2329815T3 (es) 2009-12-01
CA2587283A1 (en) 2006-05-18
EP1814555B1 (en) 2009-08-19
CA2587283C (en) 2013-01-15
US20100267694A1 (en) 2010-10-21
HRP20090513T1 (hr) 2009-10-31
US20070265245A1 (en) 2007-11-15
PT1814555E (pt) 2009-09-30
NZ554858A (en) 2009-10-30
ATE439843T1 (de) 2009-09-15
PL1814555T3 (pl) 2010-01-29
IL182767A (en) 2011-07-31
KR20070085470A (ko) 2007-08-27
PE20061051A1 (es) 2006-10-26
CY1110538T1 (el) 2015-04-29
IL182767A0 (en) 2007-09-20
UA88655C2 (ru) 2009-11-10
NO20072285L (no) 2007-06-13
CN101056641A (zh) 2007-10-17
RU2396957C2 (ru) 2010-08-20
RS51138B (sr) 2010-10-31
US20120302552A1 (en) 2012-11-29
HK1104235A1 (en) 2008-01-11
US20130225559A1 (en) 2013-08-29
DE602005016141D1 (de) 2009-10-01
AU2005303778A1 (en) 2006-05-18
EP1814555A1 (en) 2007-08-08
AU2005303778B2 (en) 2011-02-17
RU2007122391A (ru) 2008-12-20
JP2008519810A (ja) 2008-06-12
DK1814555T3 (da) 2009-12-07
SI1814555T1 (sl) 2009-12-31
WO2006051111A1 (en) 2006-05-18
ZA200703884B (en) 2009-07-29
TW200631584A (en) 2006-09-16
BRPI0517818A2 (pt) 2010-03-16

Similar Documents

Publication Publication Date Title
ZA200810113B (en) Method for the treatment and prevention of ocular disorders
IL195256A0 (en) Compositions of r(+)and s(-)pramipexole and methods of using the same
EP1765388B8 (de) Kombinationstherapie zur vorbeugung oder behandlung der alzheimerschen erkrankung sowie set hierfür
DE602004026113D1 (de) Glp-1-verbindungen
DK1687049T3 (da) Sprøjter, sprøjtegrænseflader og sprøjtestempler til anvendelse med medicinske injektorer
TW200637522A (en) Skin treatment articles and methods
WO2004006853A3 (en) Treatment and prophylaxis with 4-1bb-binding agents
PL376373A1 (en) Selected cgrp antagonists, method for production and use thereof as medicament
IL168056A0 (en) Selected cgrp antagonists, method for production and use thereof as medicament
EA200802213A1 (ru) Способы лечения заболеваний крови
ZA200700904B (en) Method of treating sjögren's syndrome
EP1797186A4 (en) EXPRESSION SYSTEM, COMPONENTS OF THIS EXPRESSION SYSTEM, AND METHODS OF USE
GB0416508D0 (en) Therapeutic agents
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
WO2004004653A3 (en) Methods for treating psychosis associated with interferon-alpha therapy
NO20072285L (no) S-mirtazapin for behandling av hetetokter
SG139747A1 (en) Inhibitors of the mutant form of kit
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
ZA201000581B (en) 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives,preparation and therapeutic use thereof
IL178827A0 (en) Use of reboxetine for the treatment of pain
ATE306977T1 (de) Schaukel für behinderte
MXPA05011699A (es) Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
PT2234966E (pt) Derivados de azetidinas, sua preparação e sua aplicação em terapia
DK1244438T3 (da) Anvendelse af beta-adrenoceptorantagonister til fremstilling af et medikament til behandling af sygdomme i den ydre nethinde
GB0410238D0 (en) Therapeutic agents